MTOR_COMPLEXES

Structural and biophysical characterization of the human mTOR kinase and its signaling complexes

Coordinatore	UNIVERSITAET BASEL    more  Organization address address: Petersplatz 1 city: BASEL postcode: 4003 contact info Titolo: Prof. Nome: Timm Cognome: Maier Email: send email Telefono: +41 61 267 21 76 Fax: +41 61 267 21 09
Nazionalità Coordinatore	Switzerland [CH]
Totale costo	184˙709 €
EC contributo	184˙709 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2012-IEF
Funding Scheme	MC-IEF
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-03-01   -   2015-02-28

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	UNIVERSITAET BASEL  Organization address address: Petersplatz 1 city: BASEL postcode: 4003 contact info Titolo: Prof. Nome: Timm Cognome: Maier Email: send email Telefono: +41 61 267 21 76 Fax: +41 61 267 21 09	CH (BASEL)	coordinator	184˙709.40

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Cell growth and proliferation are fundamental processes whereby organisms accumulate mass and are therefore tightly regulated. Regulation is achieved by a complex network of signaling pathways responding to various environmental cues. A crucial nutrient and energy-sensitive pathway is centered on the Serine/Threonine kinase mechanistic target of rapamycin (mTOR). In the cell, mTOR interacts with several proteins to form two multi-subunit signaling complexes: mTORC1 and mTORC2. mTORC1 responds to the intracellular energy state reflected in amino acid and oxygen levels and integrates extracellular signals from growth factors to control cell size and proliferation. mTORC2 responds to growth factors and its downstream targets regulate cell survival and cytoskeletal organization. Consequently, deregulation of mTOR signaling is directly linked to human disorders like obesity, type II diabetes or cancer, which makes mTOR a highly relevant pharmaceutical target. Although several aspects of mTOR signaling have been understood, the lack of intermediate to high-resolution structures impairs detailed understanding of complex assembly, function and regulation. We therefore propose to determine the structures of human mTOR complexes and their subunits by X-ray crystallography. The intended research involves initial medium-throughput expression screening of mTORC1/2 subunits in bacterial and insect cells followed by a biophysical characterization of the expressed proteins. Guided by the biophysical analysis, we will establish in vitro reconstitution protocols and identify promising candidate complexes for high-throughput crystallization screening, crystal optimization and structure determination. The structures should provide first insights into the organization of human mTOR (sub)complexes and their subunits. The proposed research will be of high general impact in academic and pharmaceutical research and will therefore significantly strengthen European scientific excellence.'